Join to View Full Profile
450 Brookline Ave.Boston, MA 02215
Dr. Thapa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bicky Thapa is an oncology specialist located in Boston, MA, with subspecialty expertise in genitourinary oncology. He completed his residency in Internal Medicine at Cleveland Clinic Foundation/Fairview Hospital and his fellowship in Hematology and Medical Oncology at the Medical College of Wisconsin Affiliated Hospitals. Dr. Thapa also earned an MS in Clinical & Translational Science. He currently practices at the Dana-Farber Cancer Institute and has served as a clinical fellow and resident in previous positions. His recent publications focus on oncology research, including investigations into somatic alterations, renal and prostate cancer, and prophylaxis for multiple myeloma patients.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2021 - 2024
Clinical & Translational Science Institute MS, Clinical & Translational Science, 2020 - 2024
Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 2016 - 2019
ArMed Forces Medical College PuneClass of 2009
Certifications & Licensure
MA State Medical License 2023 - 2027
WI State Medical License 2019 - 2025
OH State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsClinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang
Prostate Cancer and Prostatic Diseases. 2025-06-01 - Successful Targeting of SomaticAlterations With Belzutifan in Two Cases.Bicky Thapa, Aditya Shreenivas, Kathryn Bylow, Hui-Zi Chen, Ben George
Journal of Immunotherapy and Precision Oncology. 2024-11-01 - Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma.Mingee Kim, Jessica Arabi, Cole McCoy, Anita D'Souza, Saurabh Chhabra
Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01
Lectures
- Clinical characteristics and outcome of metaplastic breast cancer: A retrospective tertiary care center experience.2019 ASCO Annual Meeting - 6/1/2019
- Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI).2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Quick Takes from Original Research Presented at the 2018 NCCN Annual ConferenceJune 10th, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
